The same authors, investigating the mechanism by which ERRα regulates the expression of IL-8 in CRC cells revealed that XCT-790 treatment or ERRα gene silencing decreased the promoter activity of IL-8. The gene discussed is ESRRA; the disease is colorectal carcinoma.